K Iwamoto
- Molecular Biology top 10%
- Physiology top 5%
- Epidemiology top 10%
- Endocrinology, Diabetes and Metabolism top 5%
- Surgery
- Co-authors
- Y YazakiC D KlaassenY. AkanumaTakashi KadowakiHiroyuki TamemotoKazuhiko UmesonoTakuya FujiwaraHiroyoshi Horikoshi
- Topics
- Drug Transport and Resistance Mechanisms (4 papers)Antibiotics Pharmacokinetics and Efficacy (4 papers)Diet and metabolism studies (3 papers)
- Journals
- Journal of Clinical InvestigationBiochemical and Biophysical Research CommunicationsJournal of Pharmacology and Experimental Therapeutics
- Partner nations
- JapanUnited StatesGreece
In The Last Decade
K Iwamoto
25 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Molecular Biology 750
- Physiology 732
- Epidemiology 369
- Endocrinology, Diabetes and Metabolism 201
- Surgery 176
Countries citing papers authored by K Iwamoto
This map shows the geographic impact of K Iwamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Iwamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Iwamoto more than expected).
Fields of papers citing papers by K Iwamoto
This network shows the impact of papers produced by K Iwamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Iwamoto. The network helps show where K Iwamoto may publish in the future.
Co-authorship network of co-authors of K Iwamoto
This figure shows the co-authorship network connecting the top 25 collaborators of K Iwamoto. A scholar is included among the top collaborators of K Iwamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Iwamoto. K Iwamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 12 | |
| 3 | 9 | |
| 4 | Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.breakdown → | 875 |
| 5 | [Abnormalities of electrocardiographic P wave morphology and the relationship to electrophysiological parameters of the atrium in patients with idiopathic paroxysmal atrial fibrillation]. | 18 |
| 6 | 7 | |
| 7 | 108 | |
| 8 | 3 | |
| 9 | 181 | |
| 10 | 4 | |
| 11 | 3 | |
| 12 | 16 | |
| 13 | 10 | |
| 14 | 2 | |
| 15 | 1 | |
| 16 | 12 | |
| 17 | 13 | |
| 18 | [Cephalexin preparation with prolonged activity (author's transl)]. | 4 |
| 19 | 44 | |
| 20 | 137 |
About K Iwamoto
K Iwamoto is a scholar working on Pharmacology, Pharmacology and Cellular and Molecular Neuroscience, having authored 25 papers that have together received 1.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Diet and metabolism studies (3 papers). The work is most often cited by research in Physiology (732 citations), Endocrine and Autonomic Systems (116 citations) and Endocrinology, Diabetes and Metabolism (201 citations). K Iwamoto has collaborated with scholars based in Japan, United States and Greece. Frequent co-authors include Y Yazaki, C D Klaassen, Y. Akanuma, Takashi Kadowaki, Hiroyuki Tamemoto, Kazuhiko Umesono, Takuya Fujiwara, Hiroyoshi Horikoshi, Yusaku Mori and Kohjiro Ueki. Their work appears in journals such as Journal of Clinical Investigation, Biochemical and Biophysical Research Communications and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.